Pharmafile Logo
Pharmafocus logo
Advanced Search

AbbVie

Showing 15 posts of 235 posts found.

Baxter to split in two next year

March 28, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro

Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …

News

Major new launches for 2014

March 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10

 AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …

Feature
Abbvie image

AbbVie expands into Singapore

February 10, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology

AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …

News
Abbvie image

AbbVie ‘pleased’ with first year

February 3, 2014
Sales and Marketing AbbVie, Abbott, CLL, EMA, HIV, Humira

Rheumatoid arthritis treatment Humira – as expected – has driven AbbVie in its first year as a standalone company, accounting …

News
servier image

Servier signs cancer partnership

January 29, 2014
Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …

News
Abbvie image

AbbVie advances oncology drug

January 21, 2014
Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib

AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer.  This …

News
Abbvie image

AbbVie posts strong results for Hep C pill

December 11, 2013
Research and Development, Sales and Marketing 3D, AbbVie, FDA, Gilead, hep C

AbbVie’s investigational hepatitis C pill cured 96% of difficult-to-treat patients in a late-stage clinical trial and looks set to muscle …

News
abbvie image

CLL drug achieves ‘unprecedented’ remissions

December 9, 2013
Research and Development, Sales and Marketing AbbVie, CML, Genentech, abt-199

AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …

News
EMA image

Court annuls EMA data decision

December 5, 2013
Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency

The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …

News
Ablynx image

AbbVie signs $840m RA deal

September 25, 2013
Sales and Marketing AbbVie, Ablynx, RA, alx

News
AbbVie

Galapagos and AbbVie in $405m cystic fibrosis deal

September 25, 2013
Research and Development, Sales and Marketing AbbVie, Galapagos, cystic fibrosis

News
dr_robert_brooks_web

Robert Brooks joins Achilles from Abbott

September 10, 2013
Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, Abbott, achilles, brook

Supply chain firm Achilles has hired Dr Robert Brooks to be a Business Development director from pharma firm Abbott. Brooks …

Appointment

Marginal sales increase for Abbott

July 18, 2013
Sales and Marketing AbbVie, Abbott, Q2

Abbott’s second quarter results saw the company buffeted by currency exchange issues – primarily the yen weakening against the US …

News
Orencia image

Orencia matches Humira

June 13, 2013
Sales and Marketing AbbVie, Abbott, Humira, Orencia, RA

Bristol-Myers Squibb is hoping its biologic Orencia can grab a little more of the rheumatoid arthritis market after demonstrating non-inferiority …

News
Abbvie image

AbbVie and Galapagos extend deal

May 21, 2013
Sales and Marketing AbbVie, Crohn's, Galapagos

AbbVie and Belgian biotech Galapagos have bolted on a development programme for Crohn’s disease to the selective JAK1 inhibitor they …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026